Fully human antibodies against N-cadherin
US8703920B2 · kind B2 · utility
1Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2009 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Mar 9, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70525
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present application provides fully human antibodies against N-Cadherin for therapeutic and diagnostic methods in cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.